Digitisation | May 01, 2023
Aptar Digital Health and Healint collaborate for Central Nervous System
The partnership will capitalize on the combined capabilities of the two organizations
The partnership will capitalize on the combined capabilities of the two organizations
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
Specialty Chemicals grew 38% YoY for FY23
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Q4 results was challenging driven by steep fall in CDMO revenues and higher upfront cost of Capex projects and R&D projects
The YP-P10 pre-clinical head-to-head study, jointly conducted by five people including Dr. Kyungho Park of Naason Science
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Subscribe To Our Newsletter & Stay Updated
